SCHEMBL5035123

SCHEMBL5035123

O=C(O)c1csc(N(C(=O)c2ccc(Cl)cc2Cl)c2ccc(OC(F)(F)F)cc2)n1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 2/20 0.42
MARS1 P56192 1/20 0.42
GCGR P47871 1/20 0.40
GIPR P48546 1/20 0.40
TRPM8 Q7Z2W7 1/20 0.38
TRPV1 Q8NER1 1/20 0.38
AKR1C2 P52895 1/20 0.38
AKR1C1 Q04828 1/20 0.38
LDHA P00338 2/20 0.37
EIF4E P06730 1/20 0.37
LTC4S Q16873 1/20 0.36
CYP3A4 P08684 4/20 0.36
SCN10A Q9Y5Y9 1/20 0.36
KDM4E B2RXH2 1/20 0.36
TSHR P16473 1/20 0.35
CASP1 P29466 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5038957 0.91 LDHA (0.39) DHODHMARS1GCGRGIPRTRPM8
SCHEMBL5032539 0.88 KDM4E (0.43) DHODHGCGRGIPRAKR1C2AKR1C1
SCHEMBL5034952 0.88 CYP3A4 (0.46) LDHACYP3A4KDM4ETSHRCASP1
SCHEMBL5041129 0.87 CYP3A4 (0.41) DHODHMARS1GCGRGIPRTRPM8
SCHEMBL5035778 0.87 RAB9A (0.46) MARS1LDHALTC4SCYP3A4KDM4E
SCHEMBL5035020 0.87 NPC1 (0.39) DHODHMARS1GCGRGIPRTRPV1
SCHEMBL5034827 0.83 EPHX2 (0.40) GCGRGIPRSCN10A
SCHEMBL5034825 0.83 EPHX2 (0.40) GCGRGIPRSCN10A
SCHEMBL5035047 0.82 HSD11B1 (0.40) SMN1; SMN2
SCHEMBL5036201 0.80 CYP3A4 (0.42) CYP3A4KDM4ETSHRCASP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371751-B2 Thiazole derivatives HOFFMANN-LA ROCHE INC. (US) 2008-05-13 US disclosed
EP-1694673-B1 THIAZOLE DERIVATES HOFFMANN LA ROCHE (CH) 2008-01-16 EP disclosed
EP-1694673-A1 NOVEL THIAZOLE DERIVATES F.HOFFMANN-LA ROCHE AG (CH) 2006-08-30 EP disclosed
US-20050153962-A1 Thiazole derivatives HOFFMANN-LA ROCHE INC. 2005-07-14 US disclosed
WO-2005058887-A1 NOVEL THIAZOLE DERIVATES F. HOFFMANN-LA ROCHE AG (CH) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050153962-A1 Thiazole derivatives CNR1, CNR2, GPR119 DHODH 2367/4885MARS1 3337/4885GCGR 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.